Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Thrivite RX is a prescription-strength prenatal multivitamin and mineral supplement developed and marketed by Method Pharmaceuticals. It is specifically formulated to provide essential nutritional support for women during pregnancy and the postnatal period, including both lactating and non-lactating mothers. The formulation contains 1 mg of folic acid, which is critical for the prevention of neural tube defects, along with a comprehensive blend of vitamins (A, C, D3, E, and B-complex) and minerals (calcium, iron, zinc, magnesium, copper, and iodine). Thrivite RX is intended for use under the supervision of a licensed medical practitioner to address the increased micronutrient demands of pregnancy and to prevent or treat vitamin and mineral deficiencies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Thrivite RX.